Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dissecting miRNA-Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine.
Chatzopoulou F, Kyritsis KA, Papagiannopoulos CI, Galatou E, Mittas N, Theodoroula NF, Papazoglou AS, Karagiannidis E, Chatzidimitriou M, Papa A, Sianos G, Angelis L, Chatzidimitriou D, Vizirianakis IS. Chatzopoulou F, et al. Among authors: theodoroula nf. Cells. 2022 Feb 10;11(4):607. doi: 10.3390/cells11040607. Cells. 2022. PMID: 35203258 Free PMC article.
The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study.
Vizirianakis IS, Chatzopoulou F, Papazoglou AS, Karagiannidis E, Sofidis G, Stalikas N, Stefopoulos C, Kyritsis KA, Mittas N, Theodoroula NF, Lampri A, Mezarli E, Kartas A, Chatzidimitriou D, Papa-Konidari A, Angelis E, Karvounis Η, Sianos G. Vizirianakis IS, et al. Among authors: theodoroula nf. BMC Cardiovasc Disord. 2021 Jun 8;21(1):284. doi: 10.1186/s12872-021-02092-5. BMC Cardiovasc Disord. 2021. PMID: 34103005 Free PMC article.
A Risk-Stratification Machine Learning Framework for the Prediction of Coronary Artery Disease Severity: Insights From the GESS Trial.
Mittas N, Chatzopoulou F, Kyritsis KA, Papagiannopoulos CI, Theodoroula NF, Papazoglou AS, Karagiannidis E, Sofidis G, Moysidis DV, Stalikas N, Papa A, Chatzidimitriou D, Sianos G, Angelis L, Vizirianakis IS. Mittas N, et al. Among authors: theodoroula nf. Front Cardiovasc Med. 2022 Jan 18;8:812182. doi: 10.3389/fcvm.2021.812182. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35118145 Free PMC article.
The histone methyltransferase inhibitor A-366 enhances hemoglobin expression in erythroleukemia cells upon co-exposure with chemical inducers in culture.
Papagiannopoulos CI, Theodoroula NF, Kyritsis KA, Akrivou MG, Kosmidou M, Tsouderou K, Grigoriadis N, Vizirianakis IS. Papagiannopoulos CI, et al. Among authors: theodoroula nf. J Biol Res (Thessalon). 2021 Jan 6;28(1):2. doi: 10.1186/s40709-020-00132-3. J Biol Res (Thessalon). 2021. PMID: 33407944 Free PMC article.
Correction to: The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study.
Vizirianakis IS, Chatzopoulou F, Papazoglou AS, Karagiannidis E, Sofdis G, Stalikas N, Stefopoulos C, Kyritsis KA, Mittas N, Theodoroula NF, Lampri A, Mezarli E, Kartas A, Chatzidimitriou D, Papa-Konidari A, Angelis E, Karvounis Η, Sianos G. Vizirianakis IS, et al. Among authors: theodoroula nf. BMC Cardiovasc Disord. 2021 Jun 21;21(1):309. doi: 10.1186/s12872-021-02122-2. BMC Cardiovasc Disord. 2021. PMID: 34154527 Free PMC article. No abstract available.
12 results